Chapter/Section Purchase

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Open-Angle Glaucoma Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Prostaglandin Analogs (PGAs)
1.2.3 Combination of PGAs
1.2.4 Other
1.3 Market by Application
1.3.1 Global Open-Angle Glaucoma Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Open-Angle Glaucoma Therapeutics Market Perspective (2017-2028)
2.2 Open-Angle Glaucoma Therapeutics Growth Trends by Region
2.2.1 Open-Angle Glaucoma Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Open-Angle Glaucoma Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Open-Angle Glaucoma Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Open-Angle Glaucoma Therapeutics Market Dynamics
2.3.1 Open-Angle Glaucoma Therapeutics Industry Trends
2.3.2 Open-Angle Glaucoma Therapeutics Market Drivers
2.3.3 Open-Angle Glaucoma Therapeutics Market Challenges
2.3.4 Open-Angle Glaucoma Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Open-Angle Glaucoma Therapeutics Players by Revenue
3.1.1 Global Top Open-Angle Glaucoma Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Open-Angle Glaucoma Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Open-Angle Glaucoma Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Open-Angle Glaucoma Therapeutics Revenue
3.4 Global Open-Angle Glaucoma Therapeutics Market Concentration Ratio
3.4.1 Global Open-Angle Glaucoma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Open-Angle Glaucoma Therapeutics Revenue in 2021
3.5 Open-Angle Glaucoma Therapeutics Key Players Head office and Area Served
3.6 Key Players Open-Angle Glaucoma Therapeutics Product Solution and Service
3.7 Date of Enter into Open-Angle Glaucoma Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Open-Angle Glaucoma Therapeutics Breakdown Data by Type
4.1 Global Open-Angle Glaucoma Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Open-Angle Glaucoma Therapeutics Forecasted Market Size by Type (2023-2028)
5 Open-Angle Glaucoma Therapeutics Breakdown Data by Application
5.1 Global Open-Angle Glaucoma Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Open-Angle Glaucoma Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Open-Angle Glaucoma Therapeutics Market Size (2017-2028)
6.2 North America Open-Angle Glaucoma Therapeutics Market Size by Type
6.2.1 North America Open-Angle Glaucoma Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Open-Angle Glaucoma Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Open-Angle Glaucoma Therapeutics Market Share by Type (2017-2028)
6.3 North America Open-Angle Glaucoma Therapeutics Market Size by Application
6.3.1 North America Open-Angle Glaucoma Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Open-Angle Glaucoma Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Open-Angle Glaucoma Therapeutics Market Share by Application (2017-2028)
6.4 North America Open-Angle Glaucoma Therapeutics Market Size by Country
6.4.1 North America Open-Angle Glaucoma Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Open-Angle Glaucoma Therapeutics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Open-Angle Glaucoma Therapeutics Market Size (2017-2028)
7.2 Europe Open-Angle Glaucoma Therapeutics Market Size by Type
7.2.1 Europe Open-Angle Glaucoma Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Open-Angle Glaucoma Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Open-Angle Glaucoma Therapeutics Market Share by Type (2017-2028)
7.3 Europe Open-Angle Glaucoma Therapeutics Market Size by Application
7.3.1 Europe Open-Angle Glaucoma Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Open-Angle Glaucoma Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Open-Angle Glaucoma Therapeutics Market Share by Application (2017-2028)
7.4 Europe Open-Angle Glaucoma Therapeutics Market Size by Country
7.4.1 Europe Open-Angle Glaucoma Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Open-Angle Glaucoma Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Type
8.2.1 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Application
8.3.1 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Region
8.4.1 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Open-Angle Glaucoma Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Open-Angle Glaucoma Therapeutics Market Size (2017-2028)
9.2 Latin America Open-Angle Glaucoma Therapeutics Market Size by Type
9.2.1 Latin America Open-Angle Glaucoma Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Open-Angle Glaucoma Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Open-Angle Glaucoma Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Open-Angle Glaucoma Therapeutics Market Size by Application
9.3.1 Latin America Open-Angle Glaucoma Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Open-Angle Glaucoma Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Open-Angle Glaucoma Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Open-Angle Glaucoma Therapeutics Market Size by Country
9.4.1 Latin America Open-Angle Glaucoma Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Open-Angle Glaucoma Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Type
10.2.1 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Application
10.3.1 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Country
10.4.1 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Open-Angle Glaucoma Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Aerie Pharmaceuticals Inc.
11.1.1 Aerie Pharmaceuticals Inc. Company Details
11.1.2 Aerie Pharmaceuticals Inc. Business Overview
11.1.3 Aerie Pharmaceuticals Inc. Open-Angle Glaucoma Therapeutics Introduction
11.1.4 Aerie Pharmaceuticals Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2017-2022)
11.1.5 Aerie Pharmaceuticals Inc. Recent Developments
11.2 Allergan Plc
11.2.1 Allergan Plc Company Details
11.2.2 Allergan Plc Business Overview
11.2.3 Allergan Plc Open-Angle Glaucoma Therapeutics Introduction
11.2.4 Allergan Plc Revenue in Open-Angle Glaucoma Therapeutics Business (2017-2022)
11.2.5 Allergan Plc Recent Developments
11.3 Bausch Health Companies, Inc.
11.3.1 Bausch Health Companies, Inc. Company Details
11.3.2 Bausch Health Companies, Inc. Business Overview
11.3.3 Bausch Health Companies, Inc. Open-Angle Glaucoma Therapeutics Introduction
11.3.4 Bausch Health Companies, Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2017-2022)
11.3.5 Bausch Health Companies, Inc. Recent Developments
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Open-Angle Glaucoma Therapeutics Introduction
11.4.4 Novartis AG Revenue in Open-Angle Glaucoma Therapeutics Business (2017-2022)
11.4.5 Novartis AG Recent Developments
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Details
11.5.2 Pfizer Inc. Business Overview
11.5.3 Pfizer Inc. Open-Angle Glaucoma Therapeutics Introduction
11.5.4 Pfizer Inc. Revenue in Open-Angle Glaucoma Therapeutics Business (2017-2022)
11.5.5 Pfizer Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer